Aronex Pharmaceuticals, Inc.
Records under this name other than patents Aronex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Aronex Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,074,769 | Oligonucleotide inhibitors of bcl-xL Lapsed on the fee record Ended Jul 11, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2010 | From the USPTO record |
| US 6,323,185 | Anti-viral guanosine-rich oligonucleotides and method of treating HIV Formerly held Lapsed on the fee record Ended Nov 27, 2009 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2009 | From the USPTO record |
| US 6,200,597 | Formulation and use of carotenoids in treatment of cancer Lapsed on the fee record Ended Mar 13, 2009 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2009 | From the USPTO record |
| US 6,184,369 | Anti-viral guanosine-rich oligonucleotides Lapsed on the fee record Ended Feb 6, 2009 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2009 | From the USPTO record |
| US 6,150,339 | Anti-viral guanosine-rich oligonucleotides Lapsed on the fee record Ended Nov 21, 2008 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2008 | From the USPTO record |
| US 6,355,785 | Guanosine-rich oligonucleotide integrase inhibitors Lapsed on the fee record Ended Mar 12, 2006 · From the USPTO record | Lapsed on the fee record | Ended Mar 12, 2006 | From the USPTO record |
| US 6,288,042 | Anti-viral guanosine-rich tetrad forming oligonucleotides Lapsed on the fee record Ended Sep 11, 2005 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2005 | From the USPTO record |
| US 6,069,132 | Phosphazole compounds Lapsed on the fee record Ended May 30, 2004 · From the USPTO record | Lapsed on the fee record | Ended May 30, 2004 | From the USPTO record |
| US 5,567,604 | Anti-viral guanosine-rich oligonucleotides Term ended Term ended no later than Oct 22, 2016 · Low confidence | Term ended | Term ended no later than Oct 22, 2016 | Low confidence |
| US 5,587,458 | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof Term ended Term ended no later than Dec 24, 2016 · Low confidence | Term ended | Term ended no later than Dec 24, 2016 | Low confidence |